Podcasts about ALD

32nd Ward Alderman Scott Waguespack joins Steve Dale to talk about the success that was had with the ‘No Kings’ protests in Chicago. Ald. Waguespack later discusses details surrounding state lawmakers missing the fiscal cliff deadline that does not address the $771 million budget deficit with the Regional Transportation Authority — which oversees CTA, Metra […]

The Hidden Lightness with Jimmy Hinton – Hudson's pediatrician initially dismissed the signs that Twyla spotted. But his mom, listening to the voice of someone who knew her child day in and day out, pressed further. That decision, sparked by a teacher's concern, opened the door to an early diagnosis of adrenoleukodystrophy (ALD) — a rare and...

Fyrsti tölvuleikur íslenska tölvuleikjafyrirtækisins Myrkur Games sem nefnist Echoes of the End eða Bergmál endalokanna í lauslegri þýðingu er að koma út í sumar eftir átta ára þróunarvinnu. Leikurinn er sá fyrsti sem fyrirtækið framleiðir og sameinar spennandi bardagakerfi, fjölbreyttar þrautir, og hjartnæma sögu í fantasíuheimi sem sækir innblástur í íslenskt landslag. Aldís Amah Hamilton leikkona leikur aðalhetju leiksins og sagði frá honum ásamt Magnúsi Guðrúnarsyni, handritshöfundi, sem býr til heiminn. Einar Sveinbjörnsson veðurfræðingur kom í Veðurspjallið og talaði um hvernig veðrið getur haft áhrif á tómstundir að sumri, golfið, hlaupa-og hjólreiðafólk og íþróttamót barna og ungmenna. Hann ræddi líka um hvort frostnætur að undanförnu hafi áhrif á gróðurinn og veðurútlit næstu daga þar á meðal 17.júní sem er á næsta leiti. Og lesandi vikunnar var María Elísabet Bragadóttir rithöfundur sem deildi með okkur bókunum sem hún hefur verið að lesa og þeim sem hafa haft mest áhrif á hana. Hún sagði einnig frá því hvað er framundan hjá henni og hvernig viðtökurnar hafa verið við smásagnasafni hennar Herbergi í öðrum heimi sem er að koma fyrir augu lesenda erlendis auk þess sem smásagnasafn hennar Sápufuglinn var tilnefnd til Bókmenntaverðlauna Evrópusambandsins í fyrra og hlaut þar sérstaka viðurkenningu. Tónlist í þættinum í dag: Everybody´s Talking / Harry Nilsson Fragile / Sting Don´t stop / Fleetwood Mac UMSJÓN HELGA ARNARDÓTTIR OG FANNEY BIRNA JÓNSDÓTTIR

Ald. Bennett Lawson, 44th Ward, joins Lisa Dent to discuss accessory dwelling units (ADUs). Mayor Brandon Johnson does not have the City Council votes needed to allow single family homeowners to turn parts of their property into revenue generating ADUs city-wide. Ald. Lawson has advocated for over year to integrate this system and hopes that […]

Masked ICE agents detained 10 immigrants in Chicago's South Loop on June 4, as city lawmakers, protesters and advocates for people in the U.S. without legal status attempted to disrupt the operation. Reset talks to Ald. Byron Sigcho-Lopez of the 25th Ward, Ald. Rossana Rodriguez-Sanchez of the 33rd Ward, and Ald. Anthony Quezada of the 35th Ward, who were on the scene. For a full archive of Reset interviews, head over to wbez.org/reset.

25th Ward Alderman Byron Sigcho Lopez joins Lisa Dent live from an ICE detention center claiming that 10 people have been detained without due process. Ald. Sigcho Lopez says that 10 people from south Michigan were arriving at a immigration facility in Chicago and then detained by ICE with no warrant.

Aldía con el Congreso – Miercoles28 de mayo de 2025 Una síntesis informativa del trabajolegislativo, de representación y fiscalización del Parlamento Nacional.

Ald. Bennett Lawson, 44th Ward, joins Lisa Dent to talk about vacation rentals in Chicago. Ald. Lawson shares that while most hosts are responsible, there are some circumstances where the hosts are not present or easily contacted. Ald. Lawson would like some more transparency and clarity to protect his and other communities in the city.

Í þessari viku flytjum við hér í Samfélaginu ellefu umfjallanir úr smiðjum nemenda í blaða- og fréttamennsku við Háskóla Íslands. Í dag flytjum við fimm umfjallanir: Alma Sól Pétursdóttir fjallar um óhefðbundin, óformleg og krefjandi skátamerki. Ásrún Aldís Hreinsdóttir fjallar um brúnkukremsnotkun íslenskra ungmenna og brúnkukremsfíkn. Baldvin Þór Hannesson fjallar um nýja kynslóð íslenskra rappara og listahópinn FlySouth. Birta María Hallsteinsdóttir fjallar um tónlist og gervigreind. Halldór Ingi Óskarsson fjallar um incel-menningu. Við kíkjum líka í heimsókn í Þjóðskalasafn Íslands og veltum okkur upp úr einkaskjalasöfnum með Þórunni Marel Þorsteinsdóttur, verkefnastjóra hjá Þjóðskjalasafni Íslands.

The ASX 200 rose 36 points to 8269 (0.4%). 11-week high. Disappointing in some respects as defensive stocks saw sellers move to more leverage assets. Banks slipped with ANZ Ex-dividend, the Big Bank Basket down to $261.90 (-0.5%). MQG pushed another 3.7% ahead, with other financials doing well. HMC is up 3.7%, and RPL is rallying 5.7%. ZIP was the standout, up 8.8%, with XYZ bouncing 5.9%. REITs sold off as rates moved higher, 10-year yields up to 4.43%. Defensive industrials fell, COL and WOW went down hard, TCL fell 2.2%, and TLS dropped 2.6%. Tech did well but off highs. WTC is up 4.9% and XRO modestly higher, up 1.7%, with the All-Tech Index up 3.1%. In resources, iron ore drifted back a little, BHP up 2.1% and FMG up 2.7% with base metal stocks also in demand, MIN up 9.8% and LTR up another 3.5%. S32 had a great day up 5.6%. Gold miners were sold off on bullion weakness. NST was down 4.6%, with NEM down only 1.8% as EVN fell 5.3%. LYC dropped 3.8%on rare earth supply from China resuming. Oil and gas stocks are better, WDS up 3.7%, and STO rallying another 2.9%. Uranium stocks paused. Coal was a happy place, WHC up 3.2%. In corporate news, RIC successfully raised $125m to buy DNL's fertilizer distribution business. PNV is doing well on diabetes trials, and ALD rose 2.2% as it sold an NZ business. ASK rejected a takeover offer from Ki. On the economic front, consumer sentiment lifted on election results. Asian markets mixed, Japan up 1.7% with China flat and HK sliding back 1.5%.Want to invest with Marcus Today? The Managed Strategy Portfolio is designed for investors seeking exposure to our strategy while we do the hard work for you. If you're looking for personal financial advice, our friends at Clime Investment Management can help. Their team of licensed advisers operates across most states, offering tailored financial planning services.  Why not sign up for a free trial? Gain access to expert insights, research, and analysis to become a better investor.

Chicago Way w/John Kass (05/12/25): This week, Ald. Ray Lopez (15th) joins John Kass & Jeff Carlin to look at why he thinks Chicago Mayor Brandon Johnson perpetuating a patronage scheme by steering ‘PlayStreets’ contracts away from Latino wards and into wards where Mayor Johnson is trying to curry favor. Also, Ald. Lopez also hints […]

At WCPT's 20th anniversary live broadcast from Max and Benny's Restaurant in Northbrook, Illinois, Joan Esposito is joined by Ald. Scott Waguespack, member of the Chicago City Council representing the 32nd Ward; Marj Halperin, Democratic analyst, political commentator on "The Mincing Rascals" podcast, fill-in host for WCPT, and a moderator of the Hideout's live conversation series; and Tom Moss of Indivisible Chicago and a moderator of the Hideout's live conversation series.

Ald. Brendan Reilly, 42nd Ward, joins Lisa Dent to discuss his potential bid for Cook County President. While not making an official announcement for his candidacy, the long-time Chicago politician believes he is fit for the role, and suggests that what voters want is common sense politics, and someone who ‘has a vision for the […]

2nd Ward Alderman Brian Hopkins joins Lisa Dent to discuss his latest solution to the ‘teen takeovers’. Ald. Hopkins has previously tried to pass a curfew to prevent the takeovers from happening, but was unable to get the support. However, Ald. Hopkins says he has a compromise ordinance that has the votes to pass despite […]

Ald. Leni Manaa-Hoppenworth, 48th Ward, joins Lisa Dent to discuss a proposed ordinance that would change the zoning on Broadway from Montrose to Devon Avenues. Ald. Manaa-Hoppenworth shares how the changes would affect the surrounding communities.

Sam continues his assignment as Springfield Lucky Horseshoes Chief Storyteller Jamie Toole welcomes Mark Selvaggio of morning sponsor Selvaggio Steel, Ward 4 Ald. Larry Rockford and Double-J himself, Jeff Jarrett.See omnystudio.com/listener for privacy information.

This week's expert, Hepatologist and Key Opinion Leader Mazen Noureddin, joins Roger to discuss major advances in drug development over the past year. He covers a range of different drug classes, focusing on stages of development and the range of options within each class. First, Mazen discusses a tremendously exciting group of FGF-21 agents, specifically mentioning Akero Therapeutics's efruxifermin, 89bio's pegozafermin, and Boston Pharmaceuticals's efimosfermin. He points to efruxifermin's 96-week results to suggest that FGF-21s might be appropriate for a wide range of patients, the idea that the drug's duration of effect may make the idea of “induction therapy” less appropriate, and the exciting early data on cirrhosis patients. He also mentions pegozafermin's publication of data in the New England Journal of Medicine and efimosfermin's promising data based on monthly dosing. Next, Mazen provides some detail on the various incretin agonist options, why hepatologists are particularly excited about combinations that include a glucagon agent, and what kinds of results we might expect in upcoming trials. Finally, Mazen discusses other promising compounds in later-stage development, including the pan-PPAR lanifibranor and the FASN inhibitor denifenstat. He notes ongoing work on new classes and combination therapies. 

his conversation is the concluding segment of  SurfingMASH's coverage of the AASLD Emerging Trends Conference on the SLD Spectrum diseases: MASLD, MetALD and ALD. In addition to co-hosts Louise Campbell and Roger Green, panelists include EASL Secretary General Aleksander Krag, hepatologist Alex Lalos and Jenn Leigh Jones, Founder of the Society for Sober Livers Survival patient advocacy group.The conversation starts with Roger questioning whether it is a good or bad idea to conduct separate studies on medicines' effect on MetALD patients. He notes Anna Marie Diehl's presentation at the Conference, which suggested that regardless of organ, all cell senescence and death results from iron overload, and asks whether we should be studying this phenomenon. Aleksander agrees that important questions around iron exist and should be addressed in future research. He places this issue in context by noting that after decades of failed drug trials, SLD research has produced a string of exciting successes using different modes of action. The group turns to discuss cirrhosis, based on recent presentations from Akero Therapeutics for its agent efruxifermin. Alex notes that his quick read of slides revealed that some of the cirrhosis patients had fairly advanced disease. He expresses a high level of enthusiasm that the prospective MASLD therapies discussed in this meeting will be the third major advance during his career in medicine.Roger asks the group two closing questions: one lesson each panelist is taking from the meeting and one message they would like to share with listeners. The group members all land in a similar place: there is a spectrum running from MASLD through MetALD to ALD and we are learning how their commonalities and differences are the keys to developing better treatments and guidelines.

00:00:00 - Surf's Up: Season 6 Episode 4 Surfing the MASH Tsunami concludes its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on pivotal messages that attendees took away from the conference and what messages they would like to share with listeners. Our newsmaker, Fatty Liver Alliance and CEO Mike Betel, discusses the lessons he has taken from being invited to a far wider swath of conferences this year and shares the messages he delivers to these new audiences. Finally, our expert, hepatology research and key opinion leader Mazen Noureddin, discusses recent advances in drug development, focusing on agents in Phase 3 trials.00:04:24 - IntroductionHost Roger Green briefly describes this episode's three sections and one key lesson from each.00:06:03 - Roundtable: Highlights from the AASLD Emerging Trends Conference, Part 4This is the concluding portion of our Emerging Trends Conference Roundtable. The group focuses on key lessons they have learned and messages they would like listeners to take from this conversation.  The pivotal idea is that SLD is a spectrum running from MASLD through MetALD to ALD. Researchers and treaters will all do best in developing and implementing therapies and guidelines with this thought in mind. Aleksander Krag stresses this idea and notes that, with several different classes of drugs demonstrating positive impact, it will be an exciting decade ahead as we learn how to apply these drugs along the spectrum. Jenn Jones and Alex Lalos note the importance of identifying MetALD, although Jenn noted that it does not seem wise to conduct trials solely with MetALD patients at this time.  00:22:04 - Newsmaker: Mike Betel on the Increased Visibility of Patient AdvocatesThis week's newsmaker, Mike Betel, has experienced a significant increase in the number of conferences at which he is invited to speak or appear on a panel. This discussion centers around the reasons Mike believes this is happening and the message(s) he delivers. To Mike, his most important contribution lies in the amount of information he sends back from each event, many of which surpass 30% download rates (and some even hit 50%). He discusses his value in diabetes, endocrinology and obesity meetings, where he brings a "liver" perspective and co-education opportunity to these events. The entire experience has taught him about the need not to stigmatize patients and reinforced his belief in the importance of tailoring care to patients' needs and personalities. 00:49:28 - Expert: Mazen Noureddin on the Exciting MASLD Drug Development EnvironmentHepatologist and Key Opinion Leader Mazen Noureddin joins Roger to discuss major advances in drug development over the past year. He covers a range of different drug classes, focusing on stages of development and the range of options within each class. Specifically, he discusses the FGF-21 agents, the range of patients for whom they might be appropriate, how efruxifermin's 96-week results may make the idea of "induction therapy" less appropriate,  and the exciting early data on cirrhosis patients. He provides some detail on the various incretin agonist options, why hepatologists are particularly excited about combinations that include a glucagon agent, and what kinds of results we might expect in upcoming trials. He goes on to discuss the pan-PPAR lanifibranor, the FASN inhibitor denifenstat, and notes ongoing work on new classes and combination therapies. In general, he paints, I think, not a rosy, but an extremely optimistic picture of what the future will be for patients who need to be treated for fatty liver. 01:09:38 - Business Report Roger discusses the next Roundtable and provides some details on SurfingMASH's coverage of the upcoming EASL Congress.

This week's Expert is Jeff McIntyre, Vice President, Liver Programs at the Global Liver Institute. His major topic is how recent high-level FDA job cuts might affect MASH drug and diagnostics development. He also shares reactions to FibroSIGHT, HistoIndex's new digital pathology service for clinical practice. Highlight: Recent job cuts at the FDA will produce chaos in government and slow response to any emerging crises.Second Highlight: Patient self-advocacy becomes even more important in this environment.The conversation takes place on April 1, which lends context to Jeff's opening comment about the rate and nature of change in Washington, DC. He and Roger quickly focus on high-level job cuts at the FDA. Jeff believes that the clearest outcome from these changes is that the government will be less able to respond promptly and in a medically appropriate manner to future health crises. Jeff agrees with former FDA Commissioner Rob Califf's comment that the FDA as we know it "is dead," and that we have little idea what the future holds. A slower-moving, more chaotic government with a Secretary of HHS who minimizes pharmacotherapies for alternative therapies presents a challenge for all SLD patients. Jeff states that patients need to become more vigilant self-advocates (even more than they are today). He also identifies patient advocacy organizations like GLI as a place patients can go to seek the guidance and support they need from patient advocates. Finally, the conversation turns to discuss FibroSIGHT. Jeff describes FibroSIGHT as "exactly where we should be and should not be at the same time," a technology that takes a significant step forward in understanding and patient support, but one that ties us to biopsy as a standard for clinical care. Jeff and Roger agree this issue will play out over the coming years. 

Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on what studies on bariatric surgery and drugs in development can tell us about future treatment and explore some clinical trial questions. Guest Surfers include Professor Aleksander Krag of the University of Southern Denmark, the current Secretary-General of EALS, hepatologist Alexander Lalos of Robert Wood Johnson hospital, and Jenn Leigh Jones, founder of the Society for Sober Livers Survival, now part of the Fatty Liver Foundation. Aleksander Krag starts by discussing a presentation on what we can learn from bariatric surgery in terms of fibrosis reduction and why pharmacotherapies work (or not). He envisions a day where we have multiple treatment options and understanding how each works for specific types of patients, leading to robust, cost-effective, patient-specific treatment algorithms.  Alex Lalos describes how presentations on FGF-21s in advanced fibrosis and cirrhosis have whetted his appetite and Jenn Jones asks questions regarding ALD patient trial selection and assignment and clinical endpoints for cirrhosis trials. 

00:00:00 - Surf's Up: Season 6 Episode 3Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on what studies on bariatric surgery and drugs in development can tell us about future treatment and explore some clinical trial questions. Our newsmaker, HistoIndex Director of Clinical Development Yukti Choudhury, introduces us to FibroSIGHT, which provides clinicians with highly precise biopsy analysis. Finally, our expert, Global Liver Institute Vice President, Liver Programs Jeff McIntyre, discusses the implications of recent US government job cuts on future MASH treatment options and patient care.00:04:35 - IntroductionHost Roger Green briefly describes this episode's three sections and one key lesson from each.00:05:45 - Roundtable: Highlights from the AASLD Emerging Trends Conference, Part 3This portion of our Emerging Trends Conference Roundtable looks at how therapy might evolve over time. Aleksander Krag starts by discussing a presentation on what we can learn from bariatric surgery in terms of fibrosis reduction and why pharmacotherapies work (or not). He envisions a day where we have multiple treatment options and understanding how each works for specific types of patients, leading to robust, cost-effective, patient-specific treatment algorithms.  Alex Lalos describes how presentations on FGF-21s in advanced fibrosis and cirrhosis have whetted his appetite and Jenn Jones asks questions regarding ALD patient trial selection and assignment and clinical endpoints for cirrhosis trials. 00:16:55 - Newsmakers: FibroSIGHT Brings Clinical Trial Analytics to Clinical Practice Use of BiopsyYukti Choudhury, Director of Clinical Development at HistoIndex, joins Roger Green to discuss FibroSIGHT, a new HistoIndex service that allows clinicians to use HistoIndex's Second Harmonic Generation (SHG) technology to determine specific CRN fibrosis level for patients with inconclusive NIT results.  Yukti states that demand for this technique could equal 163,000 cases this year and rising to one million by 2028. She provides practical cues on ordering the test and its reimbursement. Roger shares his long-standing respect for SHG and the clarity it produces. He notes the economic benefit of determining whether a patient has F2 fibrosis, which is indicated for pharmacotherapy, vs.F1, which is not indicated. He sees clear benefit, but expresses concern that any option requiring more biopsies will reduce the number of patients treated.00:41:49 - Patient Advocate and Policy Expert Jeff McIntyre Discusses the Implications of FA/NIH Job Cuts on MASLD Patient CareGlobal Liver Institute Vice President, Liver Programs Jeff McIntyre joins Roger to discuss the April 1 job reductions at the FDA, explore implications for the entire MASLD community, and to ask what patients can and should do. Jeff and Roger note that the job changes will create significant uncertainty and probably reduce the government's ability to respond to future health crises. Jeff notes former FDA Commissioner Rob Califf's comment that the FDA as we know it "is dead," and that we have little idea what the future holds. According to Jeff, patients need to become even more vigilant self-advocates and also seek the guidance and support they need from patient advocacies. Finally, the conversation turns to discuss FibroSIGHT. Jeff describes FibroSIGHT as "exactly where we should be and should not be at the same time," a technology that takes a large step forward in understanding and patient support, but one that ties us to biopsy as a standard for clinical care. Jeff and Roger agree this issue will play out over the coming years. 01:09:18 - Business ReportRoger thanks listeners quoting a letter from one of them, and describes the next round of episodes. 

Ald. Brendan Reilly, 42nd Ward, joins Lisa Dent to discuss an ordinance that would protect tenants and pets. After multiple pets were shocked by electricity in the River North neighborhood, petitions were signed to address the issue, bringing it to Ald. Reilly's attention.

2nd Ward Alderman Brian Hopkins joins Lisa Dent to discuss the latest ‘teen takeover’ that took place last Friday in the Streeterville neighborhood. Ald. Hopkins details how officials are attempting to monitor and be ready for future instances. Then, Ald. Hopkins reviews the reasons for the 12 arrests, warns of the violence that these takeovers […]

00:00:00 - Surf's Up: Season 6 Episode 2Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on disease epidemiology and what it can teach us about the relative importance of alcohol and diet on disease progression. Our newsmaker, hepatology KOL and frequent Surfer Hannes Hagstrom, discusses what a recent paper demonstrates about the impact of MASLD on 15-year mortality and cause of death and how this information can improve patient care. Finally, our Expert, Shelbyville, Indiana internist Emily Ann Andeya, discusses her path from practicing internal medicine to focus on liver health (HINT: the common theme is insulin resistance).00:04:40 - IntroductionHost Roger Green briefly describes this episode's three sections and one key lesson from each.00:05:49 - Roundtable: Highlights from the AASLD Emerging Trends Conference, Part 2 The second portion of our Roundtable focuses on relative impact of alcohol and diet on disease progression and overall mortality and morbidity. It starts with Aleksander Krag sharing the highlights of his epidemiology presentation at the Emerging Trends Conference. Dr. Krag points out that while the vast majority of SLD patient live with MASLD, the vast majority of hospitalized patients and those living with late-stage cirrhosis live with ALD. Similarly, for the average patient, living with MetALD is more lethal than living with MASLD. Aleksander points out another challenge in defining where a patient lives on the ALD -> MetALD -> MASLD spectrum: patients' level of alcohol consumption is likely to change over time and many ALD or MetALD cirrhosis patients stop drinking altogether. The rest of this section considers the importance of stigma in correctly classifying patients and why genetics may become key to a message that minimizes patient stigma.00:25:50 - Newsmaker: Hepatology Researcher and KOL Hannes Hagstrom of the Karolinska Institute joins Roger to discuss cause-specific mortality in Swedish MASLD patientsOn March 24, the Journal of Hepatology posted a paper titled Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden. Co-author Hannes Hagstrom joins Roger to discuss the paper's key findings and implications for care. The key finding: living with MASLD leads to a significant increase in 15-year mortality. The most frequent cause of death among MASLD patients is cardiovascular disease, but the greatest increases in relative risk were due to HCC (HR ~ 35) and extra-hepatic cancers (HR ~ 26). Hannes points out that these results can serve as the beginning of a process where physicians can compute the risk at which individual patients place themselves through diet or alcohol patterns, which can aid patient understanding of the disease.00:44:22 - Experts: Internist Emily Ann Andeya discusses how she developed the commitment to treating liver disease that made her a "unicorn" in the words of one AASLD panelist and also brought her to attend the Emerging Trends Conference last monthRoger first met Emily Ann Andeya when she asked a question at a session of last fall's The Liver Meeting, and again at the Emerging Trends Conference, where Emily and her colleagues were likely the only primary care physicians in the room. Emily describes the path by which she went from wanting to be a cardiologist during medical school in the Philippines through years of nursing in the US to primary care practice and, how, focus on the liver as a key to overall metabolic health. Listen as Emily explains the importance of understanding insulin resistance in her transition, and how her vision affects the way she and her colleagues practice, the goals they set, and the exceptional levels of care they achieve.01:08:56 Business Report

Ald. Bill Conway, 34th Ward, joins Lisa Dent to discuss the ‘Get Behind the Vest’ pancake breakfast to raise money for bulletproof vests for Chicago police officers. Then, Ald. Conway discusses ongoing city issues.

Bítið á Bylgjunni með Heimi, Lilju og Ómari   Aldís Erna Pálsdóttir, fuglafræðingur ræddi við okkur um stöðu og ógnir sem steðja að mófuglum. Eggert Þór Kristófersson, forstjóri landeldisfyrirtækisins First Water, ræddi við okkur um uppgang fyrirtækisins.   Hanna Katrín Friðriksson, atvinnuvegaráðherra ræddi veiðigjöld, hveiti og fleira. Þröstur Ólafsson og Lilja Kristjánsdóttir í samtökum aðstandenda og fíknisjúkra ræddu við okkur um minningarathöfn í Fríkirkjunni í kvöld.   Matarhorn Bítisins hóf göngu sína með alls kyns brauðsalötum, brauði og kökum. Oddný Anna Björnsdóttir, framkvæmdastjóri Samtaka smáframleiðanda og aðildarfélags þess, Beint frá býli, var á línunni. Lagakeppni Bítisins

00:00:00 - Surf's Up! Season 6 Episode 1SurfingMASH kicks off our sixth season in our new format, with three major elements to each episode. This week's Roundtable and Newsmakers segments focused on two recent conferences that took a multispecialty perspective on the range of medical and psychological issues affecting steatotic liver disease (a new concept specialty: steatology.") Our Expert this week is our co-host Jörn Schattenberg, discussing the educational and conceptual challenges of readying Europe for the EMA approval of resmetirom later this year.00:03:58 - Introductions and GroundbreakersHost Roger Green describes the new v2.0 format. He introduces the guests for this month's Roundtable discussion of the AASLD Emerging Trends conference: co-host Louise Campbell, hepatology KOL and EASL Secretary-General Aleksander Krag, Alcohol Use Disorder and Alcohol Liver Disease patient advocate and Sober Livers patient support organization co-founder Jenn Leigh Jones, and clinical hepatology Alexander Lalos. 00:15:46 - Roundtable: Highlights from the AASLD Emerging Trends Conference, Part 1The first portion of our Roundtable focuses on the emerging recognition throughout hepatology that MASLD, MetALD and ALD are best described as a disease spectrum, rather than discreet diseases. This has implications for the medical specialties involved in treatment and the entire way we look at this diseases.00:32:35 - Newsmakers: Arizona Liver Health Institute Chief Medical Officer Naim Alkhouri and Fatty Liver Alliance Founder Mike Betel Discuss the 2025 Deser Liver ConferenceNow in its fourth year, the Arizona Liver Health Institute's Desert Liver Conference has become a major multispecialty event on the Winter conference agenda. Arizona Liver Health Chief Medical Officer and hepatology KOL Naim Akhouri and patient advocate and Fatty Liver Alliance Founder Mike Betel join Roger Green to discuss the conference, including what makes it unique. Listen to Naim introduce a new description of the science of SLD.00:55:21 - Experts: SurfingMASH co-host and hepatology KOL Jörn Schattenberg joins Roger Green to discuss how Europe is preparing for the launch of resmetirom and his own focus on this issueOur third co-host, Jörn Schattenberg, could not join the February roundtable discussion. Here, he joins Roger to update listeners on his activities over the past six months. Most of the discussion centers around the necessary steps for Europe to prepare for the launch of resmetirom (anticipated to occur later this year), particularly given that the overall environment is more "siloed."01:11;15 - Wrap-up: Roger presents "the shortest Business Report ever"Roger discusses one continuing feature of Business Reports in the future from today and leaves all his other topics for next week.

Stephanie Lulay, Executive editor and Co-Founder of Block Club Chicago, joins Bob Sirott to share the latest Chicago neighborhood stories. She provides details on: Chicago Fur Ban Fails In City Council After Black Caucus Backlash: Alderpeople rejected Ald. Ray Lopez's (15th) proposal to ban the sale of all new fur products by a 19-26 vote. Local […]

Election Day is April 1. In case you missed it, every single Madison City Council seat is up for grabs. But what does the City Council do anyways? And how can you stay engaged with the people making the decisions that impact your daily life? We caught up with outgoing District 2 Ald. Juliana Bennett to get the scoop. Want to know about the statewide elections on your ballot? Check out our conversation with Cap Times reporter Andrew Bahl. Find your alder here. And don't forget to vote! You can find your polling place and more here.  Wanna talk to us about an episode? Leave us a voicemail at 608-318-3367 or email madison@citycast.fm. We're also on Instagram!  You can get more Madison news delivered right to your inbox by subscribing to the Madison Minutes morning newsletter.  Looking to advertise on City Cast Madison? Check out our options for podcast and newsletter ads.  Learn more about the sponsors of this March 11th episode: Doyenne Group Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Hermene Hartman, Chicago media pioneer and founder of N'Digo, joins Lisa Dent to discuss her upcoming article. Ald. Ray Lopez has called for the the banning new fur sales in Chicago. Dr. Hartman explains that there are larger issues to worry about in the city than banning fur.

John Maytham speaks with Ald. JP Smith, Mayoral Committee Member for Safety and Security, about a troubling case of extortion that has devastated a local business. After receiving an anonymous email from a concerned listener, JP Smith investigated the matter and now shares his insights into the growing extortion crisis, its impact on businesses, and what is being done to combat it.See omnystudio.com/listener for privacy information.

Bu mektûb, Muhammed Ma'sûm-i Kâbilîye yazılmışdır. Sevenlerin sıkıntılara, üzüntülere dayanmaları lâzım geldiği bildirilmekdedir:“Fakîrleri seven kardeşim! Kalbinde sevgi taşıyanların sıkıntı ve üzüntü çekmeleri lâzımdır. Dervîşliği seçenlerin dertlere, sıkıntılara alışması lâzımdır.Fârisî beyt tercemesi: Seni sevmek, dert ve gam tatmak içindir, Yoksa, râhat etdirecek şeyler çokdur.Sevgili, sevenin çok üzülmesini ister. Böylece, kendinden başkasından büsbütün soğumasını, kesilmesini bekler. Sevenin râhatlığı, râhatsızlıkdadır. Âşıka en tatlı gelen şey, sevgili için yanmakdır. Sükûnet bulması çırpınmakdadır. Râhatı, yaralı olmakdadır. Bu yolda istirâhat aramak, kendini sıkıntıya atmakdır. Bütün varlığını sevgiliye vermek, ondan gelen herşeyi seve seve kapmak acısını, ekşisini, kaşları çatmadan almak lâzımdır. Aşk içinde yaşamak böyle olur. Elinizden geldiği kadar böyle olunuz! Yoksa, gevşeklik hâsıl olur. Sizin çalışmanız iyi idi. Bunun dahâ artmasını beklerken, azalıverdi. Fekat üzülmeyiniz. Eğer, kendinizi bu duraklamadan kurtarırsanız, eskisinden dahâ iyi olur. Sizi bu dağınıklığa sürükleyen şeylerin, toparlanmanıza da sebeb olacaklarını biliniz! Böylece, çalışmanız artar. Vesselâm.”146.“Oğlum Şerefeddîn Hüseynin mektûbu geldi. Allahü teâlâya hamd olsun ki, fakîrleri hâtırlamakla şereflenmekdesiniz. Aldığınız vazîfeyi çok yaparak zemânlarınızı kıymetlendiriniz! Fırsatı elden kaçırmayınız. Geçici olan şânlar, şerefler sizi aldatmasın. Dünyâ lezzetleri, hakîkî lezzetlerden mahrûm etmesin.Fârisî beyt tercemesi:Sana söyliyeceğim hep şudur: Çocuksun, yol ise korkuludur.Allahü teâlâ, bir kulunu gençlikde tevbe etmeğe kavuşdurursa ve bu tevbesini bozmakdan korursa, ne büyük ni'met olur. Diyebilirim ki, bütün dünyâ ni'metleri ve lezzetleri, bu ni'metin yanında, büyük deniz yanındaki bir damla su gibidir. Çünki bu ni'met, insanı Allahü teâlânın rızâsına, sevgisine kavuşdurur. Bu ise, dünyâ ve âhıret ni'metlerinin hepsinin üstündedir. Âl-i İmrân sûresinin onbeşinci ve Tevbe sûresinin yetmişüçüncü âyetinde meâlen, “Allah'ın râzı olması nimeti dahâ büyüktür” buyuruldu. Doğru yolda olanlara ve Muhammed Mustafâya “aleyhi ve alâ âlihissalevâtü vetteslîmâtü etemmühâ ve ekmelühâ” uymakla şereflenenlere selâm olsun!” RabbaniSahabîlerden biri şöyle dedi: Bir gün Peygamberimiz, aramızda gülüşürken çıkagelmişti. Bize, “Cehennem ardınızdayken nasıl gülersiniz? Vallahi, sizi gülerken görmemeliyim!" dedi ve yüzünü dönerek giti. Sanki başlarımıza birer kartal konmuş gibi olmuştuk. Fakat, az sonra yanımıza gelerek şu müjdeyi verdi: "Biraz önce Cebrail gelerek bana şöyle dedi. Yüce Allah buyuruyor ki: "Niçin kullarımın ümidini rahmetimden kesiyorsun? Kullarıma Benim affedici ve merhametli olduğumu, bunun yanında azabımın da ağır olduğunu bildir."ّدَاصرملابلّكَ برّنَ اBütün peygamberlerin ortak nasihati. Utanmadıktan sonra dilediğini yap.İyilikte kötülükte bulaşıcıdır."İnsanlar için hak yolunu kapatan beş şey vardır:Cahillikten rahatsız olmamak, dünya hırsı, cimrilik, amelde riya, kendi fikrini beğenmek." Hz. Ali ra.Bir vehabi yazdı sen ölünce cenaze namazına asla gelmicem. Hiç cevap vermem ama buna yazdım: Benim cenaze namazıma 1000 Peygamber gelecek, sen eksik kal nolur.“Güneşin Görevi Işık Saçmaktır! Yarasalar Rahatsız oluyor Diye, Güneş Bu Görevinden Vazgeçecek Değil Ya!” Şems-i TebriziŞeytan taşlamaktan tavaf yapamıyoruz!Başarı, en iyi intikamdır.Yiğit 1000 gün yaşar fırsat bir gün düşerBereket diye bişey var İslam'da. Kurtuluş savaşında Yunan nüfusu 10 milyon; Türkiye 10 milyon. Yıl 2025. Yunan yine 10 milyon; Türkiye 85 milyon.Korkularının üstüne git! Agresif ol ve yüzleş onlarla. Sert saldır! Vücudunda bir yer tutulup ağrıdığında, masör kişi o bölgeye sert bir masaj yapar, ödeme dönüşmüş olan kas yapını yumuşatır ve ağrı biter.Mülk Allahındır yazıyo apartmanda. Altında sahibinden satılık yazısı var!“Kendi ayıbı, insanların ayıbını görmekten alıkoyan kimseye müjdeler olsun." (Aclûnî, Keşfu'l-Hafa, II, 46)

25th Ward Alderman Byron Sigcho Lopez joins Lisa Dent to discuss the story surrounding comments a reporter made after she was being removed from his public meeting calling it a ‘mischaracterization’. Ald. Sigcho Lopez explains the events that transpired on the day of the meeting and shares what he believes was left out of the […]

New Ward 1 Ald. Jeff Cox introduces himself with a stop in the studio.See omnystudio.com/listener for privacy information.

Francia Garcia Hernandez, reporter for Block Club Chicago, joins Lisa Dent to share her story of being kicked out of a public meeting. Hernandez details what happened at a meeting in Pilsen that was announced as a public meeting. When Hernandez showed up, she was removed by Ald. Byron Sigcho Lopez’s staff.

When 25th Ward officials announced the reopening of a controversial Pilsen bar at a public meeting last week, Francia Garcia Hernandez wasn't allowed to hear what neighbors had to say about it.That's because Ald. Byron Sigcho Lopez's 25th Ward chief of staff kicked her out, a move media experts say may violate First Amendment rights that protect the press' right to investigate and report the news. Host - Jon HansenReporter - Francia Garcia HernandezRead More Here Want to donate to our non-profit newsroom? CLICK HEREWho we areBlock Club Chicago is a 501(c)(3) nonprofit news organization dedicated to delivering reliable, relevant and nonpartisan coverage of Chicago's diverse neighborhoods. We believe all neighborhoods deserve to be covered in a meaningful way.We amplify positive stories, cover development and local school council meetings and serve as watchdogs in neighborhoods often ostracized by traditional news media.Ground-level coverageOur neighborhood-based reporters don't parachute in once to cover a story. They are in the neighborhoods they cover every day building relationships over time with neighbors. We believe this ground-level approach not only builds community but leads to a more accurate portrayal of a neighborhood.Stories that matter to you — every daySince our launch five years ago, we've published more than 25,000 stories from the neighborhoods, covered hundreds of community meetings and send daily and neighborhood newsletters to more than 130,000 Chicagoans. We've built this loyalty by proving to folks we are not only covering their neighborhoods, we are a part of them. Some of us have internalized the national media's narrative of a broken Chicago. We aim to change that by celebrating our neighborhoods and chronicling the resilience of the people who fight every day to make Chicago a better place for all.

Send us a textTaegan Goddard is the founder and editor of Political Wire, one of the most widely-read political news sites over the last 25+ years. He created Political Wire in the late 1990s after stints as a Senate staffer on Capitol Hill and several years in state government in his home state of Connecticut. In this conversation, he talks his own development as a rabid political junkie, setting out early goals in the public and private sector, both encouraging and disheartening stints in government, why he decided against running for office, and starting Political Wire initially as a hobby - which has now grown into a site that is a regular stop for 10+ million readers a month. To become a paid subscriber to Political Wire to see additional content and no ads, click here.IN THIS EPISODEGrowing up as a young political junkie in Hartford, CT...Taegan runs across an early version of the internet in the 1980s...The British politician who had an important important on the structure of Taegan's life...Important lessons working for the Senate Banking Chair, Michigan Democrat Don Riegle, on Capitol Hill...Highs and lows of working for Governor Lowell Weicker and others in CT state government...Why time working in state government made Taegan forgo an early desire to run for office himself...The core lesson of his book for elected officials, You Won, Now What?, that stands the test of time...The origin story of the Political Wire news website, which goes back 3+ decades...When Taegan realized Political Wire had found an audience and developed staying power...How Taegan has maintained and grown his audience in the tumultuous space of internet political sites...Taegan's sense of how important and history-making our current era of politics is...Taegan's most effective work tool & favorite non-political website...AND Spiro Agnew, David Bradley, Jimmy Carter, Bill Clinton's best friend, Congressional Quarterly, Charlie Cook, Al D'Amato, dark horse campaigns, the Federal Reserve Board, Joe Ganim, Newt Gingrich, Michael Heseltine, the Keating 5, John Kerry, Merck, nattering nabobs, The New Republic, Ross Perot, reader freakouts, Robert Redford, Chris Riback, Joe Rogan, Stu Rothenberg, John Rowland, William Safire, Ben Thompson, Chuck Todd, Donald Trump, the Wall Street Journal, yellow legal pads...& more!

Dan Vitale joined me and discussed social media presence; attention he got from Marc Maron's podcast; Lorne Michaels seeing him; his audition for The New Show; his fluctuating weight from 1986 - 1991; Cobra Kai; streaming services give more content; Dave Chappelle, Chris Rock, Bill Burr & Louis CK; being Lorne Michaels protege; being funnier now than when he was "hot" in the '80's because he's off alcohol and drugs and older; being listed above Norm MacDonald as a SNL cast member in Rolling Stone; growing up in Island Park, Long Island; other famous Island Park residents including Al D'Amato and the basis for Tony Soprano; where he did stand up pre Covid; living through Covid and protests; going back to college and feeling like Johnny Lawrence from Cobra Kai; IPhones; Dave Attell, memories of Don Novello and Randy Quaid; wanting to know who from his cast was invited to the 40th anniversary; Joan Cusack; Anthony Michael Hall; Damon Wayans; Jon Lovitz; Nora Dunn; Dennis Miller; Danitra Vance; Terry Sweeney;  A Whitney Brown; Jim Downey; Franken & Davis; remembering the Madonna episode and the horrible week working with Chevy Chase; being with world's largest man Michael Hebrank (1100 lbs.) at the Brookhaven Rehabilitation Center; intermittent fasting; coming back for the Ron Reagan Jr. episode; residuals; current SNL; Baldwin's Trump vs. Carrey's Biden; Taran Killam; Darrell Hammond making SNL a civil service job; Alan Zweibel; and John Murray

Chicago Way w/John Kass (02/10/25): Just in time for Valentine’s Day, Ald. Ray Lopez (15th) explains the special purpose room that houses a bounty of gifts on the 5th Floor of Chicago City Call and why he thinks it will take someone special to help Chicago course-correct before it’s too late. Plus, Kasso wonders who […]

Ald. Marty Quinn pushed and passed an ordinance that forcing smoke shops selling hemp-derived THC to close while Democratic lawmakers argue over how to regulate the “loophole” products — and who can make money from selling them.Host - Jon HansenReporter - Mack LiedermanRead More Here Want to donate to our non-profit newsroom? CLICK HEREWho we areBlock Club Chicago is a 501(c)(3) nonprofit news organization dedicated to delivering reliable, relevant and nonpartisan coverage of Chicago's diverse neighborhoods. We believe all neighborhoods deserve to be covered in a meaningful way.We amplify positive stories, cover development and local school council meetings and serve as watchdogs in neighborhoods often ostracized by traditional news media.Ground-level coverageOur neighborhood-based reporters don't parachute in once to cover a story. They are in the neighborhoods they cover every day building relationships over time with neighbors. We believe this ground-level approach not only builds community but leads to a more accurate portrayal of a neighborhood.Stories that matter to you — every daySince our launch five years ago, we've published more than 25,000 stories from the neighborhoods, covered hundreds of community meetings and send daily and neighborhood newsletters to more than 130,000 Chicagoans. We've built this loyalty by proving to folks we are not only covering their neighborhoods, we are a part of them. Some of us have internalized the national media's narrative of a broken Chicago. We aim to change that by celebrating our neighborhoods and chronicling the resilience of the people who fight every day to make Chicago a better place for all.

Brian's going to buy a snowmobile, Ald. E Coyote, a huge anniversary for 'The Simpsons', and more! Chicago’s best morning radio show now has a podcast! Don’t forget to rate, review, and subscribe wherever you listen to podcasts and remember that the conversation always lives on the Q101 Facebook page. Brian & Kenzie are live every morning from 6a-10a on Q101. Subscribe to our channel HERE: https://www.youtube.com/@Q101 Like Q101 on Facebook HERE: https://www.facebook.com/q101chicago Follow Q101 on Twitter HERE: https://twitter.com/Q101Chicago Follow Q101 on Instagram HERE: https://www.instagram.com/q101chicago/?hl=en Follow Q101 on TikTok HERE: https://www.tiktok.com/@q101chicago?lang=enSee omnystudio.com/listener for privacy information.

Palestinská samospráva sáhla k nezvyklému řešení, a pozastavila činnost katarské televize Al-Džazíra na území, které ovládá. Zní to zvláštně, ale vedení v Ramalláhu mělo své velmi dobré důvody.

Proč to nejdůležitější z prezidentova projevu zapadlo; Česká opozice v roce 2024; Palestinské hnutí Fatah kontra televize Al-Džazíra; Bez hodnot se nedá udržet svoboda a demokracie; Francouzský Mayotte po cyklonu; Ivan Medek, muž staré občiny

Chicago Way w/John Kass (12/16/24): On this edition, Ald. Ray Lopez (15th) discusses what it takes for Chicago Mayor Brandon “Brandito” Johnson to have his approval rating drop to 14% and whether or not Lopez & the coalition of Alders opposing Johnson’s rubberstamp agenda can protect the citizens from another ‘parking-meter-esque’ budget deal. Plus, Kasso wonders […]

Fatty liver disease, encompassing both non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), is a prevalent condition in the United States. NAFLD affects approximately 24% of U.S. adults, translating to about 80 million individuals. Within this group, a subset develops non-alcoholic steatohepatitis (NASH), a more severe form characterized by liver inflammation and damage, affecting an estimated 1.5% to 6.5% of U.S. adults. NIDDK In this lesson I will be sharing with you an easy protocol to reverse fatty liver + the top warning signs that your liver is failing you.  The first step to repairing your liver is to avoid snacking, and practice intermittent fasting.  The second step to repairing your liver is to avoid or limit alcohol! The third step to healing your liver are the following supplements and biohacks.